Literature DB >> 18330572

Immunological mechanisms in glaucoma.

F Grus1, D Sun.   

Abstract

Glaucoma is one of the most frequent causes of blindness worldwide. The elevated intraocular pressure does not explain glaucoma in all patients but can be considered as a risk factor of the disease. There are some evidences that autoimmune mechanisms may be involved in this disorder. This review attempts to demonstrate the findings about autoimmune mechanisms in glaucoma patients. Consistent up- and down-regulations in the autoantibody profiles against ocular antigens are present in glaucoma patients. These changes in natural autoimmunity could be found in independent study populations and might be a promising tool for glaucoma detection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330572     DOI: 10.1007/s00281-008-0105-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  54 in total

1.  Immunoglobulins and Antibodies.

Authors:  Alexander Ya. Kulberg
Journal:  Russ J Immunol       Date:  1999-10

2.  Anti-brain spectrin immunoreactivity in Alzheimer's disease: degradation of spectrin in an animal model of cholinergic degeneration.

Authors:  C Fernández-Shaw; A Marina; P Cazorla; F Valdivieso; J Vázquez
Journal:  J Neuroimmunol       Date:  1997-07       Impact factor: 3.478

3.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

4.  Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.

Authors:  Franz H Grus; Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Martin B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  Antiphosphatidylserine antibodies are elevated in normal tension glaucoma.

Authors:  S Kremmer; E Kreuzfelder; R Klein; N Bontke; K B Henneberg-Quester; K P Steuhl; H Grosse-Wilde
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Effects of autoimmune NGF deprivation in the adult rabbit and offspring.

Authors:  E M Johnson; P D Gorin; P A Osborne; R E Rydel; J Pearson
Journal:  Brain Res       Date:  1982-05-20       Impact factor: 3.252

Review 7.  Pathophysiology of myasthenia gravis.

Authors:  Benjamin W Hughes; Maria Luisa Moro De Casillas; Henry J Kaminski
Journal:  Semin Neurol       Date:  2004-03       Impact factor: 3.420

8.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

Review 9.  Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection.

Authors:  Martin B Wax; Gülgün Tezel
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

10.  Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation.

Authors:  A B Poletaev; A A Abrosimova; M A Sokolov; A B Gekht; V V Alferova; E I Gusev; T Ya Nikolaeva; C Selmi
Journal:  Clin Dev Immunol       Date:  2004-06
View more
  7 in total

1.  Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma.

Authors:  Purushottam Jha; Himanshu Banda; Ruslana Tytarenko; P S Bora; N S Bora
Journal:  Mol Immunol       Date:  2011-08-06       Impact factor: 4.407

2.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

3.  Relationship between retinal morphological findings and autoantibody profile in primary Sjögren's syndrome.

Authors:  Jee Myung Yang; Hwan Heo; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2014-06-03       Impact factor: 2.447

4.  Analysis of Clinical Factors Associated with Retinal Morphological Changes in Patients with Primary Sjögren's Syndrome.

Authors:  Jee Myung Yang; Mi Sun Sung; Yong Sok Ji; Hwan Heo; Sang Woo Park
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

5.  A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Authors:  Katrin Lorenz; Yvonne Scheller; Katharina Bell; Franz Grus; Katharina A Ponto; Felix Bock; Claus Cursiefen; Jens Flach; Marta Gehring; Tunde Peto; Rufino Silva; Yossi Tal; Norbert Pfeiffer
Journal:  Trials       Date:  2017-03-16       Impact factor: 2.279

6.  Glaucoma related Proteomic Alterations in Human Retina Samples.

Authors:  Sebastian Funke; Natarajan Perumal; Sabine Beck; Silke Gabel-Scheurich; Carsten Schmelter; Julia Teister; Claudia Gerbig; Oliver W Gramlich; Norbert Pfeiffer; Franz H Grus
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

Review 7.  Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways.

Authors:  Nadine Auler; Henrik Tonner; Norbert Pfeiffer; Franz H Grus
Journal:  Biology (Basel)       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.